- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01998269
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS) (MeDS)
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS), an Assessment for Use in Clinical Settings Among English and Spanish-speaking Patients With Hypertension and Diabetes.
The study objective is to develop and test a Measure of Drug Self-Management for use in clinical settings among patients with hypertension and diabetes.
While medication non-adherence is a highly recognized public health and patient safety concern, it is rarely assessed in a routine and consistent manner in clinical settings. With the aging of the US population and rising rates of chronic disease, an increasing number of adults are being prescribed multi-drug regimens that require greater self-management skills. Despite the complexity of medication use, adherence has most commonly been measured as a limited set of behaviors (i.e., filling a prescription, taking doses). This emphasis has, over time, simplified how we think of prescription (Rx) medication use and directed attention away from the full range of tasks associated with effective Rx self-management. The field of health literacy research has deconstructed these tasks in considerable detail in recent years, and can offer insight into a more comprehensive measurement of patients' outpatient Rx use.
There is a clear need for a brief, yet inclusive, measure of adherence that can be used in clinical settings to routinely assess patients' use of complex Rx regimens. Such an assessment could be used to guide clinicians in addressing specific patient challenges to safe and appropriate medication use. In response to this need, our study proposes to develop a new assessment of medication self-management. This unique measure will utilize health literacy best practices to promote patient comprehension and ease-of-use; it will also be tailored to patients' actual regimens via electronic health record (EHR) data. Finally, the tool will be available in both English and Spanish to support use among diverse patient populations. Our study aims are to:
- Develop and refine a Measure of Drug Self-Management (MeDS) prototype.
- Inform the content, structure and delivery of the MeDS through targeted discussions with patients, providers and information technology specialists.
- Test the reliability and validity of the MeDS among patients with diabetes and hypertension
H1: The MeDS will strongly correlate with other self-report adherence measures.
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
North Carolina
-
Chapel Hill, North Carolina, Vereinigte Staaten, 27599
- Ambulatory Care Center
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- be ≥ 18 years old,
- have a diagnosis of diabetes and hypertension,
- be prescribed 3 or more drugs to treat these conditions,
- speak English or Spanish as their primary language,
- have primary responsibility for administering their own medications,
- be a registered UNC patient.
Exclusion Criteria:
- severe, uncorrectable visual, hearing or cognitive impairments that would preclude study consent or participation.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
---|
Adult patients with diabetes and hypertension
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Measure of Medication Self-Management (MeDS)
Zeitfenster: cross-sectional, 1 hour interview after clinic visit
|
The MeDS is an assessment of medication self-management skills.
The MeDS tool has 14 questions, the minimum score is 0 (poor medication self-management skills) and the maximum score is 14 (adequate self-management skills).
The internal consistency of the scale is .72
(cronbach's alpha), which is considered adequate internal consistency.
The MeDS was compared to The Morisky Medication Adherence Scale is one of the most commonly used assessments of medication adherence.
It includes 8 questions that assess various factors that can affect medication use, such as forgetfulness, busyness and side effects.
Scores range from 0 to 8, with lower scores reflecting better adherence.
|
cross-sectional, 1 hour interview after clinic visit
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Stacy C Bailey, PhD MPH, University of North Carolina, Chapel Hill
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 13-3049
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Hypertonie
-
Nantes University HospitalBeendetZirrhotischer Patient mit Verdacht auf portale Hypertension und im Rahmen eines OV-ScreeningsFrankreich